Ross Murdoch
Impact in
- Physiology top 5%
- Alzheimer's disease research and treatments
- Nutrition and Dietetics top 5%
- Trace Elements in Health
Papers in
-
- Drug-Induced Hepatotoxicity and Protection 3
- Pharmacogenetics and Drug Metabolism 2
- Oncology 2
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- Ashley I. Bush (1 shared paper)David Ames (1 shared paper)John Harrison (1 shared paper)Henrik Zetterberg (1 shared paper)Craig Ritchie (1 shared paper)Colin L. Masters (1 shared paper)Lars Lannfelt (1 shared paper)Kaj Blennow (1 shared paper)
- Journals
- Biochemical Pharmacology (1 paper)Alimentary Pharmacology & Therapeutics (1 paper)British Journal of Clinical Pharmacology (1 paper)The Lancet Neurology (1 paper)Xenobiotica (1 paper)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Ross Murdoch
5 papers receiving 650 citations
Ross Murdoch's Hit Papers
Peers
Comparison fields: 5 of 73
- Physiology 400
- Nutrition and Dietetics 215
- Pharmacology 155
- Biological Psychiatry 15
- Health, Toxicology and Mutagenesis 84
Countries citing papers authored by Ross Murdoch
This map shows the geographic impact of Ross Murdoch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Murdoch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Murdoch more than expected).
Fields of papers citing papers by Ross Murdoch
This network shows the impact of papers produced by Ross Murdoch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Murdoch. The network helps show where Ross Murdoch may publish in the future.
Co-authors
The 22 scholars most cited alongside Ross Murdoch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial Hit paper breakdown → | 2008 | 591 |
| 2 | 1995 | 31 | |
| 3 | 1991 | 15 | |
| 4 | 1991 | 13 | |
| 5 | 1992 | 11 | |
| 6 | 1988 | 1 |
About Ross Murdoch
Ross Murdoch is a scholar working on Pharmacology, Oncology, Organic Chemistry, Surgery and Urology, having authored 6 papers that have together received 662 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Malaria Research and Control (1 paper), Urinary Bladder and Prostate Research (1 paper), Alzheimer's disease research and treatments (1 paper), Anesthesia and Pain Management (1 paper) and Synthesis of heterocyclic compounds (1 paper). The work is most often cited by research in Physiology (400 citations), Nutrition and Dietetics (215 citations), Pharmacology (155 citations), Biological Psychiatry (15 citations) and Health, Toxicology and Mutagenesis (84 citations). Ross Murdoch has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Ashley I. Bush, David Ames, John Harrison, Henrik Zetterberg, Craig Ritchie, Colin L. Masters, Lars Lannfelt, Kaj Blennow, Denis J. Morgan and Richard A. Smallwood. Their work appears in journals such as Biochemical Pharmacology, Alimentary Pharmacology & Therapeutics, British Journal of Clinical Pharmacology, The Lancet Neurology and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.